GoBear is now part of Finder

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

Investing in cannabis stocks

Pot stocks to watch if you're looking to invest in the cannabis boom.

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

In only a few short years, cannabis has emerged as one of the next big market disruptors. Today, as billions of dollars pour into the sector, investors in Singapore are keen to take part in the anticipated marijuana boom.

But before you add marijuana stocks to your portfolio, consider how the legality issues that surround this product may impact profits.

What is cannabis?

Cannabis refers to plants Cannabis sativa, Cannabis indica and Cannabis ruderalis. This plant can be processed for a variety of purposes, from topical oils and food products to building materials — but it’s popularly grown and consumed for its psychoactive properties. As such, the legality, as well as public opinion of cannabis, remains divisive across the world.

For instance, the US is projected by a number of Wall Street estimates to be the largest cannabis market in the world by annual sales within a decade. Yet, the laws that govern its consumption vary by state. Some states, like Washington, Vermont and California, have legalised both recreational and medical marijuana consumption. Others, like Utah, Arizona and New York, only permit marijuana consumption for medical purposes. And in many other states, cannabis consumption is not permitted in any capacity.

Cannabis stocks are shares of any company that grows, harvests, sells, manufactures or distributes cannabis, including hemp.

Is marijuana legal in Singapore?

No. According to the Central Narcotics Board (CNB), the possession or consumption of cannabis can lead up to 10 years of imprisonment or S$20,000 fine or both. Trafficking over 500g of the drug may bring a death penalty.

However, it is legal for Singapore traders to invest in marijuana stocks since there are no laws against it.

How do I buy cannabis stocks?

  1. Choose a stock trading platform. If you’re a beginner, our table below can help you choose.
  2. Open your account. You’ll need to provide your personal details, government-issued ID and bank account information.
  3. Fund your account. Before you can start trading, you’ll need to fund your account with a bank transfer.
  4. Search for stocks. Use a stock screener to sort and filter stocks.
  5. Submit your order. Once you’ve found a security you’d like to buy, indicate how many you’d like to purchase and submit your order.
  6. Monitor your investments. Log in to your brokerage account to track the performance of your portfolio.

Cannabis stocks

Cannabis stocks are widely available and can be purchased directly from overseas exchanges, primarily those in US and Canada. If you’re interested in international cannabis stocks, you’ll need a brokerage account that offers access to global or over-the-counter stocks.

What ETFs track the cannabis category?

ETFs contain a bundle of stocks, usually hundreds, and these often track an index of stocks. There are currently no Singapore-listed cannabis ETFs, but here’s a handful listed in the US.

  • AdvisorShares Pure Cannabis ETF (YOLO)
  • Cambria Cannabis ETF (TOKE)
  • ETFMG Alternative Harvest (MJ)
  • Horizons Marijuana Life Sciences (OTC:HMLSF or TSX:HMMJ)
  • The Cannabis ETF (THCX)

Why invest in cannabis stocks?

Despite its lack of legality in many parts of the world and Singapore, cannabis remains a popular product. In US, medical marijuana was first legalised in California in 1996. And in 2012, Colorado and Washington became the first states to legalise the plant’s recreational use. Today, recreational marijuana is legal in 11 states and medical marijuana is permitted in 33 states.

The shift in attitude towards cannabis isn’t limited to the US. In 2018, Canada legalised recreational marijuana use across the country. And other international governments are reassessing their cannabis laws too, potentially paving the way for an explosion of new businesses.

On 2 December 2020, the United Nations Commission on Narcotic Drugs loosened global controls on cannabis by voting to remove cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs — where it was listed alongside some of the world’s most dangerous and highly addictive drugs (e.g. cocaine and heroin). This is seen as a huge step forward for worldwide legalisation efforts.

But Singapore, with one of the strictest drug laws in the world, has expressed its disappointment with this decision. According to the Ministry of Home Affairs, the Singapore Government believes that this outcome could mislead and send a wrong signal that the CND has softened its stance against cannabis.

Globally, as more countries becoming accepting of medical and recreational marijuana use, the cannabis market grows. And as the cannabis market grows, so do sales, profits and company valuations.

Statista reports that in 2018, the global cannabis sector was worth US$13.8 billion. By 2025, it predicts the sector will swell to US$43 billion. The cannabis market is one poised for growth — and for investors, growth means profit.

Disclaimer: The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Risks of investing in cannabis

Positive growth projections aside, cannabis may not be a practical addition to your portfolio. And that’s because this sector is riddled with risks — many of which stem from the legality issues that surround the product.

As laws that surround the legalisation of recreational marijuana continue to shift, investors must be wary about how high tax rates could impact the market. Tax rates have the potential to cripple cannabis providers in states that allow recreational marijuana because of how high consumers are taxed.

For example, in California consumers are taxed close to 45% for recreational cannabis. With taxes that high, it’s little wonder that some consumers turn to the black market to purchase their product, leaving cannabis providers high and dry.

Financing for cannabis companies is also a concern, as cannabis companies are seen as high-risk merchants in the eyes of many financial institutions. As a result, many of these banks aren’t willing to provide essential banking services and funding must be found elsewhere. One way cannabis companies can raise funds is to issue common stock, but this dilutes the holdings of existing investors.

Overall, the cannabis market seems to be gaining traction. And for investors that can tolerate risk, this is an exciting prospect. But ultimately, the variables that factor into the profitability of this market are constantly in flux — and this sort of instability can lead to price volatility.

US market projections for Cannabis stocks

The global cannabis market as a whole is expected to grow and it may gain significant traction in the US, where its legality remains contended at the federal level. The market value of the cannabis industry in the US is projected to climb to US$30 billion annually by 2025, according to New Frontier Data.

More US states have aimed at relaxing laws around its usage. New Jersey, Arizona, Montana and South Dakota in December 2020 approved ballot measures to legalise recreational use of marijuana. However, marijuana stocks fell following this news as federal elections remained in question. The MORE Act which would decriminalise marijuana at the federal level passed the House in December 2020. But its future is foggy. So it’s important to carefully analyse cannabis stocks to find where the potential long-term winners may be.

    Compare trading platforms

    Before you can buy cannabis stocks or ETFs, you’ll need to open a brokerage account. Explore your platform options below.

    Name Product Number of Stocks Shares Available Markets
    Interactive Brokers
    Access to global markets
    Yes
    Global markets
    Your capital is at risk.
    Saxo Markets
    19,000+
    Yes
    Global markets
    Your capital is at risk.
    Plus500
    2,000+
    No
    US, UK, AU, DE, FR, IT, PT, GR, JP, SG, ZA, NL, FI, BE, DK, SE, CH, ES, AT, NO, HU, CZ, IE, PL, HK
    CFD Service. Your capital is at risk.
    BlackBull Markets
    N/A
    No
    UK, HK, JP, MY, NZ, US
    CFD Service. Your capital is at risk.
    Libertex
    50+
    No
    Worldwide with exception.
    Except for: US/Australia/New Zealand/Belgium/British Virgin Islands/Guam/Lebanon/United States Minor/Outlying Islands/Northern Mariana Islands/Uganda/Philippines/Sri Lanka/Kuwait/South Africa/Azerbaijan/Canada/Armenia/Russia/Japan/Brasil.
    CFD Service. Your capital is at risk.
    Exness
    N/A
    No
    CH, VN, TH, PH, SG, ID, IN, UAE, ZA, SA, EG, BR, CR, MX
    CFD Service. Your capital is at risk.
    IG
    17,000+
    No
    DK, IE, NO, RU, DE, IT, AT, CH, ES, LU, PT, SE, FR, NL, RO, UK, US, AU, JP, SG, ZA, AE
    CFD Service. Your capital is at risk.
    loading

    Compare up to 4 providers

    Marijuana products

    While smoking weed is perhaps the most well-known use of cannabis, there are many types of businesses that are positioned to benefit from the growing sector. As more cannabis products are given the green light, we’ll see the market continue to expand. The legalisation of many of these products is new and in some cases, still underway:

    • Medicinal products. Medicinal cannabis is used for the treatment of cancer pain, epilepsy, palliative care, chemotherapy nausea, neuropathic pain, anorexia and neurological conditions. Cannabidiol, also known as CBD, is a derivative of the marijuana plant that’s become increasingly popular for medical uses in recent years.
    • Research. The scientific study of marijuana has accelerated in recent years with the discovery of many other beneficial compounds besides the psychoactive THC.
    • Recreational use. Marijuana as a recreational drug is still illegal or restricted in many states. That said, legalisation of both recreational and medical marijuana continues to roll out across the US. The plant is consumed to achieve feelings of relaxation or euphoria, but negative side effects have been reported, including headache, dizziness, nausea, delusions and hallucinations. Long-term use of the substance may cause cannabinoid hyperemesis syndrome (CHS).
    • Food products. Hemp is used as an ingredient in a range of products, including cooking oils, snacks, protein powder, cooking flour and more. The sale of food products made from hemp seeds was authorised under the Agriculture Improvement Act of 2018.
    • Building materials. Hemp is used in insulation and building construction materials under several names, including hempcrete, hemp masonry and hemplime.
    • Clothing. Hemp is broadly recognised as one of the most sustainable materials available in the manufacture of clothing.
    • Beauty products. Hemp is commonly used in various health and beauty products, such as moisturisers, lip balm, makeup and skin oils.

    Marijuana vs. hemp

    Unlike marijuana, hemp is not a narcotic. While hemp and marijuana both come from the cannabis plant, hemp has a lower component of the psychoactive THC — typically less than 0.3% — which means it has no psychoactive effects.

    Typically, hemp is used in food products, building materials and textiles. Marijuana, on the other hand, is primarily used for medicinal and recreational purposes.

    Bottom line

    The legal cannabis sector is positioned to grow in the coming years and there are a number of ways to invest. But keep in mind that past performance is not a guarantee of profit and all investments come with inherent risks.

    Explore your investment options across trading platforms and commodities before you buy.

    Frequently asked questions

    Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

    More guides on Finder

    Ask Finder

    You are about to post a question on finder.com:

    • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
    • finder.com is a financial comparison and information service, not a bank or product provider
    • We cannot provide you with personal advice or recommendations
    • Your answer might already be waiting – check previous questions below to see if yours has already been asked
    Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

    By submitting your comment or question, you agree to our Privacy Policy and Terms.

    Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
    Go to site